More than 15,000 of Accelus' FlareHawk multiplanar expandable cages have been implanted in over 11,000 patients in the U.S.
The FlareHawk lumbar fusion devices feature Accelus' Adaptive Geometry technology, which allows the implants to be inserted with a minimal insertion profile before expanding in width, height and lordosis, according to the company. The implants are designed to restore foraminal height, reestablish sagittal balance and reduce implant subsidence.
"The increased surface area after expansion and its large anterior column structural support help facilitate fusion," Robert Norton, MD, a neurosurgeon at Delray Beach (Fla.) Surgery Center, said in the release. "Because of the porosity of the cage, FlareHawk also allows for dispersion of the bone graft circumferentially around the cage, providing maximized post-pack bone graft delivery within the disc space."
FlareHawk, which is approved in 19 countries, received FDA 510(k) clearance in August 2016 and CE mark certification in April 2021.